4//SEC Filing
NEVO DORON 4
Accession 0001140361-09-022188
CIK 0001451980other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:29 PM ET
Size
6.0 KB
Accession
0001140361-09-022188
Insider Transaction Report
Form 4
BIOCANCELL THERAPEUTICS INC.BICL.TA
NEVO DORON
Director
Transactions
- Award
Employee Options
2008-12-03+20,000→ 40,000 totalExercise: $0.60Exp: 2018-12-03→ Common Stock, par value $0.01 (20,000 underlying)
Footnotes (1)
- [F1](1) 20,000 options shall vest and be exercisable on each of June 3, 2009 and December 3, 2009. The Reporting Person was granted the option on December 3, 2008, and reported the initial vested amount under the option on his Form 3 filed with the SEC on June 29, 2009. The Reporting Person is filing this Form 4 to report the remaining securities under the option.
Documents
Issuer
BIOCANCELL THERAPEUTICS INC.
CIK 0001451980
Entity typeother
Related Parties
1- filerCIK 0001286028
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 4:29 PM ET
- Size
- 6.0 KB